Details

Erdafitinib Tablets 4 mg (Erdanat-4)

Quantity

1 Box × 28 Film-Coated Tablets

Manufacturer

NATCO Pharma Ltd.

Category

Targeted Cancer Therapy (FGFR Inhibitor)

Indications

• Used for the treatment of locally advanced or metastatic urothelial carcinoma (bladder cancer) in adults with susceptible FGFR2 or FGFR3 genetic alterations, as prescribed by an oncologist.